Novavax (NVAX) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $10.08 --0%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $5.680 million versus the consensus estimate of $6.17 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marriott (MAR) Tops Q3 EPS by 19c; Guides EPS Higher
- Choice Hotels (CHH) Tops Q3 EPS by 5c, Beats on Revenue; Offers FY26 EPS Guidance
- Tower Semiconductor (TSEM) Misses Q3 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
